Alrex Ophthalmic Drops, Suspension 0.2pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Alrex: Ophthalmic drops, suspension (0.2%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Alrex 0.2% Ophthalmic Susp
Drug Image file default-drug-image.png
Alrex 0.2% Ophthalmic Susp

What is this Medicine?

LOTEPREDNOL (loe te PRED nol) is used in the eye to treat swelling and redness caused by certain eye conditions or surgery.

CVS Pharmacy Patient Statistics for Alrex: Ophthalmic drops, suspension(0.2%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Alrex 0.2% Ophthalmic Suspension

NDC: 242080353
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Keratitis, Allergic Conjunctivitis, Acne Rosacea, Giant Papillary Conjunctivitis (GPC), Postoperative Ocular Inflammation, Cyclitis, Iritis

Sometimes used for but not FDA approved for the following conditions:
Uveitis

Storage Information
Store upright
Protect from freezing
Store between 59 to 77 degrees F
Alrex 0.2% Ophthalmic Suspension

Reported Side Effects for Alrex 0.2% Ophthalmic Suspension

Rhinitis Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Skin Redness Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Conjunctivitis Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Eye Inflammation Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Sore Throat Incidence:
<15.0%*
Severity: MILD
Onset: DELAYED
Eye Pain Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Inflamed Eye Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Headache Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
Light Sensitivity Incidence:
5.0-15.0%*
Severity: MODERATE
Onset: EARLY
Blurred Vision Incidence:
5.0-15.0%*
Severity: MODERATE
Onset: EARLY
Epiphora Incidence:
5.0-15.0%*
Severity: MODERATE
Onset: EARLY
Itchy Eyes Incidence:
5.0-15.0%*
Severity: MILD
Onset: RAPID
Foreign Body Sensation Incidence:
5.0-15.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Alrex

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit
your own observations and experiences to benefit others.